Literature DB >> 9055794

Executive function in multiple sclerosis. The role of frontal lobe pathology.

J Foong1, L Rozewicz, G Quaghebeur, C A Davie, L D Kartsounis, A J Thompson, D H Miller, M A Ron.   

Abstract

Deficits in executive function and the relationship to frontal lesion load as detected on MRI were investigated in 42 multiple sclerosis patients. A battery of neuropsychological test examining executive skills including computerized tests of planning and spatial working memory was administered to all subjects. Performance on these tests was impaired in the patient group when compared with a group of matched controls, but not all executive skills were affected to the same extent. Although a number of executive test scores correlated with the severity of frontal lesion load, it was difficult to disentangle the specific contribution of frontal lobe pathology to the impairment on executive tasks. This study highlights the difficulties in attempting to attribute specific cognitive abnormalities to focal brain pathology in the presence of widespread disease such as in multiple sclerosis.

Entities:  

Mesh:

Year:  1997        PMID: 9055794     DOI: 10.1093/brain/120.1.15

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  44 in total

1.  Quantitative functional MR imaging of the visual cortex at 1.5 T as a function of luminance contrast in healthy volunteers and patients with multiple sclerosis.

Authors:  Scott H Faro; Feroze B Mohamed; Joseph I Tracy; Robert M Elfont; Alexander B Pinus; Fred D Lublin; Robert A Koenigsberg; Cheng Y Chen; Fong Y Tsai
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

Review 2.  Frontal-lobe involvement in spatial memory: evidence from PET, fMRI, and lesion studies.

Authors:  R P Kessels; A Postma; E M Wijnalda; E H de Haan
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

3.  Electrophysiological evidence for a defect in the processing of temporal sound patterns in multiple sclerosis.

Authors:  S J Jones; L Sprague; M Vaz Pato
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

4.  Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis.

Authors:  M Filippi; C Tortorella; M Rovaris; M Bozzali; F Possa; M P Sormani; G Iannucci; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

5.  Let's inhibit our excitement: the relationships between Stroop, behavioral disinhibition, and the frontal lobes.

Authors:  Lara H Heflin; Victor Laluz; Jung Jang; Robin Ketelle; Bruce L Miller; Joel H Kramer
Journal:  Neuropsychology       Date:  2011-09       Impact factor: 3.295

6.  Deconstructing spatial working memory and attention deficits in multiple sclerosis.

Authors:  Leon Gmeindl; Susan M Courtney
Journal:  Neuropsychology       Date:  2011-11-07       Impact factor: 3.295

Review 7.  Causes, effects and connectivity changes in MS-related cognitive decline.

Authors:  Carolina de Medeiros Rimkus; Martijn D Steenwijk; Frederik Barkhof
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

8.  Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.

Authors:  Matilde Inglese; Sumita Adhya; Glyn Johnson; James S Babb; Laura Miles; Hina Jaggi; Joseph Herbert; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-02       Impact factor: 6.200

9.  Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Authors:  R S Prakash; E M Snook; J M Lewis; R W Motl; A F Kramer
Journal:  Mult Scler       Date:  2008-08-13       Impact factor: 6.312

10.  Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophy.

Authors:  K K Mineev; L N Prakhova; A G Il'ves; G V Kataeva; A M Petrov; T N Reznikova; A V Pozdnyakov; I D Stolyarov
Journal:  Neurosci Behav Physiol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.